$12m owed to MED by Axis vs a $17m market. I wonder if this is why GT resigned as auditor. Brings into question previous Auditor statement that the going concern status is reliant on support form Axis.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025